METHODS OF DELIVERING GENE THERAPY AGENTS

Details for Australian Patent Application No. 2003256280 (hide)

Owner GENZYME CORPORATION

Inventors BASKIN, Kevin, M.; EASTMAN, Simon, J.; SCHEULE, Ronald, K.

Pub. Number AU-A-2003256280

PCT Number PCT/US03/19639

PCT Pub. Number WO2004/001049

Priority 60/390,444 24.06.02 US

Filing date 24 June 2003

Wipo publication date 6 January 2004

International Classifications

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 015/87 Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

A01N 043/04 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 031/70 - Carbohydrates

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/390,444 24.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003256280

12 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003256281-ELECTROLYTES FOR ELECTROOPTIC DEVICES COMPRISING IONIC LIQUIDS

2003256279-VERY LOW VOLTAGE HIGH EFFICIENCY PHOLED IN A P-I-N STRUCTURE